INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/10/2026
Back to search
Official data from USPTO
PLEOTHERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLEOTHERAPY
ST13
US500000079225505Class
35, 41, 42, 44
Filing
79225505
Registration
5705799
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
06/11/2026
Trademark type
Word
Nice classes
35, 41, 42, 44
Filing date
11/07/2017
Registration date
03/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2025
Last transaction
06/11/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
JAGANNATHAN, SIDDHARTH
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PHARNEXT
Representatives
JEFF D. LARSON HOLLAND & HART LLP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Compilation and management of databases and central data files in the field of pharmaceutical research and developmentscientific research regarding medicinemedicine and clinical trials; compilation of statistics for business or commercial purposes; collection and systematization of data in a central file; public relations; communicationpromoting public awareness of programs concerning the treatment of diseases
Class 41
Training services in the pharmaceutical field; publication of books and texts other than advertising texts; electronic publication of texts in the field of pharmaceutical research and developmentscientific research regarding medicineonline medicine; organization and conducting of colloquiumsconferencescongressesseminars in the pharmaceutical and medical field; teaching in the pharmaceutical field
Class 42
Pharmaceutical research and development; scientific research regarding medicine; conducting of clinical trials and studies; chemical and biological analysis for scientific research purposes; scientific research in chemistrycosmetologybiologybacteriologynutrition and biotechnology; biological research for the diagnosisprevention and treatment of neurodegenerativemetabolicinflammatorycancerous and cardiac diseasesdiabetes and obesity and any other diseases; biological research services in the field of chemicalbiological and pharmaceutical products; software design and development; scientific laboratory services; scientific research on chemical reagents for medical usebiomarkers
Class 44
Providing medical informationpharmaceutical advice using information gathered from pharmaceutical research and clinical trials
Publications
History of USPTO decisions and trademark events.
44 publications found
C71T
CANCELLED SECTION 71
10/10/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/26/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/21/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/26/2019
FIMP
FINAL DISPOSITION PROCESSED
07/26/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/26/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/08/2019
PUBO
PUBLISHED FOR OPPOSITION
01/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/19/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/30/2018
ALIE
ASSIGNED TO LIE
11/29/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
GPNX
NOTIFICATION PROCESSED BY IB
11/09/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
11/08/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/08/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
11/08/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/08/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/31/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/26/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/24/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/24/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/17/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/17/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/15/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/14/2018
RFNP
REFUSAL PROCESSED BY IB
03/30/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/15/2018
RFRR
REFUSAL PROCESSED BY MPU
03/15/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/07/2018
CNRT
NON-FINAL ACTION WRITTEN
03/06/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/27/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/20/2018
CNRT
NON-FINAL ACTION WRITTEN
02/19/2018
DOCK
ASSIGNED TO EXAMINER
02/13/2018
MAFR
APPLICATION FILING RECEIPT MAILED
02/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/29/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/25/2018
Continuous trademark protection
Get notified about every new filing that threatens PLEOTHERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.